Results showed that growth of melanoma cell line B16-F10 in wild-type mice was significantly inhibited with treatment of anti-γδ TCR or anti-NKG2D mAb compared with treatment of rat-IgG or left untreated (Figure 2(b)). This evidence concerns the gene KLRK1 and melanoma.